AnaptysBio, Inc. (LON:0HFQ)
London flag London · Delayed Price · Currency is GBP · Price in USD
36.36
-0.18 (-0.50%)
At close: Oct 31, 2025

AnaptysBio Revenue

AnaptysBio had revenue of $22.26M USD in the quarter ending June 30, 2025, with 102.93% growth. This brings the company's revenue in the last twelve months to $123.16M, up 304.17% year-over-year. In the year 2024, AnaptysBio had annual revenue of $91.28M with 432.03% growth.

Revenue (ttm)
$123.16M
Revenue Growth
+304.17%
P/S Ratio
8.67
Revenue / Employee
$905.62K
Employees
136
Market Cap
779.75M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202491.28M74.12M432.03%
Dec 31, 202317.16M6.87M66.78%
Dec 31, 202210.29M-52.89M-83.72%
Dec 31, 202163.18M-11.83M-15.77%
Dec 31, 202075.00M67.00M837.50%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Shell200.18B
BP p.l.c.134.89B
Unilever51.24B
HSBC Holdings43.13B
AstraZeneca41.24B
Rio Tinto Group39.22B
GSK plc32.17B
Barclays26.03B
Revenue Rankings